Substaging of T1 bladder carcinoma based on the depth of invasion as measured by micrometer: A new proposal

Cancer

Volumn 86, Issue 6, 1999, Pages 1035-1043

  Cheng, Liang ^a,d   Weaver, Amy L ^b   Neumann, Roxann M ^b   Scherer, Beth G ^b   Bostwick, David G ^b,c  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

^c BOSTWICK LABORATORIES   (United States)

^d INDIANA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Bladder; Cystectomy; Disease progression; Grading; Muscle invasion; Prognosis; Staging; T1

Indexed keywords

ACCURACY; ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER GRADING; CANCER GROWTH; CANCER INVASION; CANCER STAGING; CYSTECTOMY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; TRANSURETHRAL RESECTION;

ADULT; AGED; BASEMENT MEMBRANE; BIOPSY; CARCINOMA; CYSTECTOMY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; RETROSPECTIVE STUDIES; ROC CURVE; URINARY BLADDER NEOPLASMS;

EID: 0033568151     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19990915)86:6<1035::AID-CNCR20>3.0.CO;2-D     Document Type: Article

References (66)

1. Fleming ID, Cooper JS, Henson DE, Hutter RVP, Kennedy BJ, Murphy GP, et al. American Joint Committee on Cancer cancer staging manual. Philadelphia: Raven and Lippincott, 1997.
2. England HR, Paris AMI, Blandy JP. The correlation of T1 bladder tumour history with prognosis and follow-up requirements. Br J Urol 1981;53:593-7.
3. Lutzeyer W, Rubben H, Dahm H. Prognostic parameters in superficial bladder cancer: an analysis of 315 cases. J Urol 1982;127:250-2.
4. Heney NM, Ahmed S, Flanagan MJ, Frable W, Corder MP, Hafermann MD, et al. Superficial bladder cancer: progression and recurrence. J Urol 1983;130:1083-6.
5. Smith G, Elton RA, Chisholm GD, Newsam JE, Hargreave TB. Superficial bladder cancer: intravesical chemotherapy and tumour progression to muscle invasion or metastases. Br J Urol 1986;58:659-63.
6. Torti FM, Lum BL, Aston D, MacKenzie N, Faysel M, Shortliffe LD, et al. Superficial bladder cancer: the primacy of grade in the development of invasive disease. J Clin Oncol 1987;5:125-30.
7. Malmstrom P, Busch C, Norlen BJ. Recurrence, progression and survival in bladder cancer. Scand J Urol Nephrol 1987; 21:185-95.
8. Jakse G, Loidl W, Seeber G, Hofstadter F. Stage T1, grade 3 transitional cell carcinoma of the bladder: an unfavorable tumor? J Urol 1987;137:39-43.
9. Pagano F, Gabeglio A, Milani C, Bassi P, Pegoraro V. Prognosis of bladder cancer I. Risk factors in superficial transitional cell carcinoma. Eur Urol 1987;13:145-9.
10. Pagano F, Pegoraro V, Prayer-Galetti T, Pizzarella M, Milani C, Garbeglio A. Prognosis of bladder cancer II. The fate of patients with T1b transitional cell bladder cancer. Eur Urol 1987;13:305-9.
11. Abel PD, Hall RR, Williams G. Should pT1 transitional cell cancers of the bladder still be classified as superficial? Br J Urol 1988;62:235-9.
12. Pauwels RPE, Schapers RFM, Smeets AWGB, Debruyne FMJ, Geraedts JPM. Grading in superficial bladder cancer: morphological criteria. Br J Urol 1988;61:129-34.
13. Herr HW. Natural history of superficial bladder tumors: 10-to 20-year follow-up of treated patients. World J Urol 1997; 15:84-8.
14. Herr HW. High-risk superficial bladder cancer: transurethral resection alone in selected patients with T1 tumor. Semin Urol Oncol 1997;15:142-6.
15. Herr HW, Jakse G, Sheinfeld J. The T1 bladder tumor. Semin Urol 1990;8:254-61.
16. Herr H, Jakse G. pT1 bladder cancer. Eur Urol 1991;20:1-8.
17. Lundbeck F, Jacobsen F, Vaeth M. Impact of the category of early tumor recurrence on tumor progresion in bladder tumors treated by transurethral resection. Eur Urol 1989;16: 291-4.
18. Herr HW, Badalament RA, Amato DA, Laudone VP, Fair WR, Whitmore WF. Superficial bladder cancer treated with bacillus calmette-guerin: a multivariate analysis of factors affecting tumor progression. J Urol 1989;141:22-9.
19. Kaubisch S, Lum BL, Reese J, Freiha F, Torti FM. Stage T1 bladder cancer: grade is the primary determinant for risk of muscle invasion. J Urol 1991;146:28-31.
20. Takashi M, Sakata T, Murase T, Hamajima N, Miyake K. Grade 3 bladder cancer with lamina propria invasion (pT1): characteristics of tumor and clinical course. Nagoya J Med Sci 1991;53:1-8.
21. Sarkis AS, Guido D, Cordon-Cardo C, Zhang Z, Sheinfeld J, Fair WR, et al. Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression. J Natl Cancer Inst 1993;85:53-9.
22. Hasui Y, Osada Y, Kitada S, Nishi S. Significance of invasion to the muscularis mucosae on the progression of superficial bladder cancer. Urology 1994;43:782-6.
23. Mulders PFA, Hoekstra WJ, Heybroek RPM, Schapers ERFM, Verbeek ALM, Oosterhof GON, et al. Prognosis and treatment of T1G3 bladder tumours. A prognostic factor analysis of 121 patients. Eur J Cancer 194;30A:914-7.
24. Holmang S, Hedelin H, Anderstrom C, Holmberg E, Johansson SL. The importance of the depth of invasion in stage T1 bladder carcinoma: a prospective cohort study. J Urol 1997; 157:800-4.
25. Holmang S, Hedelin H, Anderstrom C, Johnansson SL. The relationship among multiple recurrences, progression and prognosis of patients with stages Ta and T1 transitional cell cancer of the bladder followed for at least 20 years. J Urol 1995;153:1823-7.
26. Birch BRP, Harland SJ. The pT1 G3 bladder tumour. Br J Urol 1989;64:109-16.
27. Stockle M, Alken P, Englemann U, Jocobi GH, Riedmiller H, Hohenfellner R. Radical cystectomy - often too late? Eur Urol 1987;13:361-7.
28. Jenkins BJ, Nauth-Misir RR, Martin JE, Fowler CG, Hope-Stone HF, Blandy JP. The fate of GSpT1 bladder cancer. Br J Urol 1989;64:608-10.
29. Bostwick DG. Natural history of early bladder cancer. J Cell Biochem 1992;161 (Suppl):31-8.
30. Prout GR, Jr., Griffin PP, Shipley WU. Bladder carcinoma as a systemic disease. Cancer 1979;43:2532-9.
31. Epstein JI, Amin MB, Reuter VR, Mostofi FK, and the Bladder Consensus Conference Committee. The World Health Organization/International Society of Urologic Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Am J Surg Pathol 1998;22: 1435-48.
32. Hasumi K, Sakamoto A, Sugano H. Microinvasive carcinoma of the uterine cervix. Cancer 1980;45:928-31.
33. Fu YS, Reagan JW. Pathology of the uterine cervix, vagina, and vulva. In: Bennington JL, editor. Major problems in pathololgy. Volume 21. Philadelphia: W.B. Saunders, 1989: 225-335.
34. Simon NL, Gore H, Shingleton HM, Soong SJ, Orr JW Jr., Hatch KD. Study of superficially invasive carcinoma of the cervix. Obstet Gynecol 1986;68:19-24.
35. Sedlis A, Sall S, Tsukada Y, Park R, Mangan C, Shingleton H, et al. Microinvasive carcinoma of the uterine cervix: a clinical-pathologic study. Am J Obstet Gynecol 1979;133:64-74.
36. Kopf AW, Welkovich B, Frankel KE, Stoppelmann EJ, Bart RS, Rogers GS, et al. Thickness of malignant melanoma: global analysis of related factors. J Dermatol Surg Oncol 1987;13:345-420.
37. Hermann GG, Horn T, Steven K. The influence of the level of lamina propria invasion and the prevalence of p53 nuclear accumulation on survival in stage T1 transitional cell bladder cancer. J Urol 1998;159:91-4.
38. Angulo JC, Lopez JI, Grignon DJ, Sanchez-Chapado M. Muscularis mucosa differentiates two populations with different prognosis in stage T1 bladder cancer. Urology 1995;45:47-53.
39. Bamber D. The area above the ordinal dominance graph and the area below the receiver operating graph. J Math Psych 1975;12:387-415.
40. Herr HW. Staging invasive bladder tumors. J Surg Oncol 1992;51:217-20.
41. Amling CL, Thrasher JB, Frazier HA, Dodge RK, Robertson JE, Paulson DF. Radical cystectomy for stages TA, T1S and T1 transitional cell carcinoma of the bladder. J Urol 1994; 151:31-6.
42. Pagano F, Bassi P, Galetti TP, Meneghini A, Milani C, Artibani W, et al. Results of contemporary radical cystectomy for invasive bladder cancer: a clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification. J Urol 1991;145:45-50.
43. Yaman O, Baltaci S, Arikan N, Yilmaz E, Gogus O. Staging with computed tomography, transrectal ultrasonography and transurethral resection of bladder tumour: comparison with final pathological stage in invasive bladder carcinoma. Br J Urol 1996;78:197-200.
44. Freeman JA, Esrig D, Stein JP, Simoneau AR, Skinner EC, Chen S, et al. Radical cystectomy for high risk patients with superficial bladder cancer in the era of orthotopic urinary reconstruction. Cancer 1995;76:833-9.
45. Skinner DG. Current state of classification and staging of bladder cancer. Cancer Res 1977;37:2838-42.
46. Skinner DG. Current perspectives in the management of high grade invasive bladder cancer. Cancer 1980;45:1866-74.
47. Cummings KB, Barone JG, Ward WS. Diagnosis and staging of bladder cancer. Urol Clin North Am 1992;19:455-65.
48. Whitmore WF Jr., Batata MA, Ghoneim MA, Grabstald H, Unal A. Radical cystectomy with or without prior irradiation in the treatment of bladder cancer. J Urol 1977;118:184-7.
49. Whitmore WF Jr., Batata MA, Hilaris BS, Reddy GN, Unal A, Ghoneim MA, et al. A comparative study of two preoperative radiation regimens with cystectomy for bladder cancer. Cancer 1977;40:1077-86.
50. See WA, Fuller JR. Staging of advanced bladder cancer. Urol Clin North Am 1992;19:663-83.
51. Esrig D, Freeman JA, Stein JP, Skinner DG. Early cystectomy for clinical stage T1 transitional cell carcinoma of the bladder. Semin Urol Oncol 1997;15:154-60.
52. Kenny GM, Hardner GJ, Murphy GP. Clinical staging of bladder tumors. J Urol 1970;104:720-3.
53. Soloway MS, Lopez AE, Patel J, Lu Y. Results of radical cystectomy for transitional cell carcinoma of the bladder and the effect of chemotherapy. Cancer 1994;73:1926-31.
54. Bracken RB, McDonald MW, Johnson DE. Cystectomy for superficial bladder cancer. Urology 1981;18:459-63.
55. Herr HW, Whitmore WF Jr., Morse MJ, Sogani PC, Russo P, Fair WR. Neoadjuvant chemotherapy in invasive bladder cancer: the evolving role of surgery. J Urol 1990;144:1083-8.
56. Bochner BH, Nichols PW, Skinner DG. Overstaging of transitional cell carcinoma: clinical significance of lamina propria fat within the urinary bladder. Urology 1994;45:528-31.
57. Younes M, Sussman J, True LD. The usefulness of the level of the muscularis mucosae in the staging of invasive transitional cell carcinoma of the urinary bladder. Cancer 1990; 66:543-8.
58. Platz CE, Cohen MB, Jones MP, Olson DB, Lynch CF. Is microstaging of early invasive cancer of the urinary bladder possible or useful? Mod Pathol 1996;11:1035-9.
59. Engel P, Anagnostaki L, Braendstrup O. The muscularis mucosae of the human urinary bladder. Scand J Urol Nephrol 1992;26:249-52.
60. Dixon JS, Gosling JA. Histology and fine structure of the muscularis mucosae. J Anat 1983;136:265-71.
61. Keep JC, Piehl M, Miller A, Oyasu R. Invasive carcinomas of the urinary bladder. Evaluation of tunica muscularis mucosae involvement. Am J Clin Pathol 1989;91:575-9.
62. Ro JY, Ayala AG, El-Naggar A. Muscularis mucosa of urinary bladder. Am J Surg Pathol 1987;11:668-73.
63. Angulo JC, Lopez JI. Re: the importance of the depth of invasion in stage T1 bladder carcinoma: a prospective cohort study [letter]. J Urol 1997;158:1922-3.
64. Cheng L, Neumann RM, Weaver AL, Spotts BE, Bostwick DG. Predicting cancer progression in patients with stage T1 bladder carcinoma. J Clin Oncol 1999; in press.
65. Murphy WW. Editorial comment. J Urol 157:804.
66. Cheng L, Neumann RM, Weaver AL, Spotts BE, Bostwick DG. Predicting cancer progression in patients with stage T1 bladder carcinoma. J Clin Oncol 1999; in press.